# CNPLE Cram V2 — Parity Batch 43B Clinical Second Pass

Date: 2026-08-09
Scope: `43b-endocrine-diabetes-thyroid-parity.json`
Result: **PASS — Canadian clinical authoring second pass**

## Exact identity contract
- `np-type-2-diabetes-diagnosis-and-initial-management`
- `np-type-1-diabetes-insulin-regimen-selection`
- `np-diabetic-ketoacidosis-recognition-and-management`
- `np-hyperosmolar-hyperglycemic-state-management`
- `np-hypoglycemia-evaluation-and-prevention`
- `np-hypothyroidism-diagnosis-and-levothyroxine-dosing`

## Clinical review
- Type 2 diabetes: PASS. Confirmation rules, type classification, metabolic-decompensation insulin and cardiorenal therapy are separated correctly.
- Type 1 diabetes: PASS. Continuous basal insulin physiology, basal/meal/correction roles, pump-failure backup and sick-day/ketone safety are explicit.
- DKA: PASS. Ketoacidosis rather than glucose alone defines resolution; potassium precedes insulin when severely low; euglycemic DKA remains visible.
- HHS: PASS. Hyperosmolality/water deficit, neurologic risk and careful correction are distinct from DKA; frailty/heart/kidney status drives fluid reassessment.
- Hypoglycemia: PASS. Immediate treatment is followed by regimen/root-cause prevention. Current Canadian 15 g / 10–15 minute recheck teaching is used for self-treatable hypoglycemia.
- Hypothyroidism: PASS. TSH-first primary disease, central-disease exception, absorption/adherence and coronary/pregnancy considerations are explicit; myxedema coma is clinical decompensation rather than a TSH number.

## Canadian source refresh
Rechecked 2026-08-09 against Diabetes Canada Hyperglycemic Emergencies, Hypoglycemia 2023, Type 1/monitoring resources and 2024 Type 2 pharmacologic guidance; and Choosing Wisely Canada / Canadian Society of Endocrinology and Metabolism endocrine recommendations updated April 2026.

## Publication boundary
Clinical authoring PASS only. Global parse/count/ID validation, exact current Full identity, source anchors, Bottom Line evidence, three eligible Quick Checks, runtime certification, learner render QA, merge and deployment remain downstream fail-closed gates.
